Home » Posts tagged with » frontotemporal lobar dementia
Yumanity secures $500m worth deal with Merck to develop therapies for neurodegenerative disorders

Yumanity secures $500m worth deal with Merck to develop therapies for neurodegenerative disorders

Massachusetts-based Yumanity Therapeutics has secured a drug development deal worth up to nearly $500 million with pharma giant Merck to develop new therapies for neurodegenerative disorders. The partnership is set to combine the drug discovery platform of Yumanity Therapeutics with the development and commercialization expertise in neuroscience of Merck. As per the deal, Merck will […]